Literature DB >> 23545100

Expression and functional role of Cdx2 in intestinal metaplasia of cystitis glandularis.

Ming-en Lin1, Danying Huang, Bi-hua Deng, Yi-song Lv, Lu Rong, You-sheng Yao.   

Abstract

PURPOSE: Cdx2 is an essential transcription factor in intestinal epithelial cell differentiation and proliferation. However, to our knowledge the expression and role of Cdx2 in the development of intestinal cystitis glandularis, a metaplastic lesion induced by chronic inflammation, remained to be explored.
MATERIALS AND METHODS: Real-time polymerase chain reaction was used to examine Cdx2, LI-cadherin and villin expression in typical and intestinal cystitis glandularis, and normal bladder tissue. Cdx2 cDNA was subcloned to the retroviral vector pLNCX2 for subsequent transfection into human bladder urothelium cells and rat bladder urothelium. Cdx2 mRNA and protein levels, and cell morphology and proliferation were assessed after transfection using real-time polymerase chain reaction, phase contrast microscopy, transmission electron microscopy and MTT assay, respectively.
RESULTS: Higher mRNA levels of Cdx2, villin and LI-cadherin were detected in intestinal cystitis glandularis compared to normal bladder and typical cystitis glandularis. Only Cdx2 groups attained statistical significance (p <0.001). Retroviral over expression of Cdx2 resulted in increased mRNA and protein expression of Cdx2 as well as villin and LI-cadherin levels, and increased cell proliferation. A distinct change in cellular morphology, in which cells resembled intestinal-like cells, was also observed in vitro and in vivo.
CONCLUSIONS: Cdx2 may have a critical role in regulating intestinal metaplasia in cystitis glandularis. Further studies are planned to assess the potential of using Cdx2 as a marker and therapeutic target for cystitis glandularis.
Copyright © 2013 American Urological Association Education and Research, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  BUC; CDH17 protein, human; CDX2 protein, human; CG; Cdx2; Ct; DMEM; Dulbecco's modified Eagle's medium; GAPDH; LI-cadherin; PBS; PCR; bladder urothelium cell; caudal-related homeobox 2; cystitis; cystitis glandularis; glyceraldehyde-3-phosphate dehydrogenase; liver-intestinal cadherin; phosphate buffered saline; polymerase chain reaction; threshold count; urinary bladder; villin

Mesh:

Substances:

Year:  2013        PMID: 23545100     DOI: 10.1016/j.juro.2013.03.109

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  5 in total

1.  The role of steroid treatment in intractable cystitis glandularis: A case report and literature review.

Authors:  Ozgur Haki Yuksel; Ahmet Urkmez; Tibet Erdogru; Ayhan Verit
Journal:  Can Urol Assoc J       Date:  2015 May-Jun       Impact factor: 1.862

2.  Recombinant lentivirus with enhanced expression of caudal-related homeobox protein 2 inhibits human colorectal cancer cell proliferation in vitro.

Authors:  Sai He; Xue-Jun Sun; Jian-Bao Zheng; Jie Qi; Nan-Zheng Chen; Wei Wang; Guang-Bing Wei; Dong Liu; Jun-Hui Yu; Shao-Ying Lu; Hui Wang
Journal:  Mol Med Rep       Date:  2015-04-03       Impact factor: 2.952

3.  Targeted CDX2 expression inhibits aggressive phenotypes of colon cancer cells in vitro and in vivo.

Authors:  Jianbao Zheng; Sai He; Jie Qi; Xiaolong Wang; Junhui Yu; Yunhua Wu; Qi Gao; Kai Wang; Xuejun Sun
Journal:  Int J Oncol       Date:  2017-06-13       Impact factor: 5.650

4.  Incidence of adenocarcinoma bladder in patients with cystitis cystica et glandularis: A retrospective study.

Authors:  Amit Agrawal; Deepak Kumar; Aditya A Jha; Puneet Aggarwal
Journal:  Indian J Urol       Date:  2020-10-01

5.  Tumor protein P63 Regulated 1 contributes to inflammation and cell proliferation of cystitis glandularis through regulating the NF-кB/cyclooxygenase-2/prostaglandin E2 axis.

Authors:  Tao Hong; Songzhe Piao; Liangxue Sun; Yiran Tao; Mang Ke
Journal:  Bosn J Basic Med Sci       Date:  2022-02-01       Impact factor: 3.363

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.